Saxenda injection sites: what the manufacturer says
This page lists where the manufacturer says Saxenda (liraglutide) can be injected in the UK, the EU and the US, in their own words, with the documents each list comes from. It is not medical advice.
Talk to a healthcare professional. The injection areas shown come from the manufacturer's product information, and the heat map is your own record. GLPMGR is not a medical device and this is not medical advice: it can't tell you where it is safe for you to inject. Talk to your doctor, pharmacist or nurse about where and how to inject, follow the instructions from your prescriber and the leaflet supplied with your medicine, and ask a healthcare professional if you are unsure, or if you have pain, lumps, bruising or any other problem at an injection site.
Where Saxenda can be injected
Manufacturer: Novo Nordisk
United Kingdom
Areas listed:
- Front of waist (abdomen)
- Front of thigh
- Upper arm
Rotation, in the manufacturer’s words: “Change the place where you inject each day to reduce the risk of developing lumps.”
Source: emc / Novo Nordisk: Saxenda Patient Information Leaflet, revised 08/2025. Checked 20 September 2026.
European Union
Areas listed:
- Abdomen
- Thigh
- Upper arm
Rotation, in the manufacturer’s words: “Change the place where you inject each day to reduce the risk of developing lumps.”
Source: EMA: Saxenda EPAR Product Information (English). Checked 20 September 2026.
United States
Areas listed:
- Abdomen
- Thigh
- Upper arm
Rotation, in the manufacturer’s words: “Change (rotate) your injection site with each injection.”
Source: FDA / DailyMed: Saxenda prescribing information and patient instructions (DailyMed, current label), revised 05/2025. Checked 20 September 2026.
Track your Saxenda injection sites in GLPMGR
GLPMGR is a private GLP-1 tracker for iPhone, iPad and Apple Watch. Choose Saxenda when you record a dose and it offers only the areas above for your region, shows a body map of where you have injected before, and shows the manufacturer’s rotation wording. It does not tell you where to inject, and it is independent of Novo Nordisk.

Coming soon to the App Store
Other medicines with the same active ingredient:
Medical disclaimer
Talk to a healthcare professional. The injection areas shown come from the manufacturer's product information, and the heat map is your own record. GLPMGR is not a medical device and this is not medical advice: it can't tell you where it is safe for you to inject. Talk to your doctor, pharmacist or nurse about where and how to inject, follow the instructions from your prescriber and the leaflet supplied with your medicine, and ask a healthcare professional if you are unsure, or if you have pain, lumps, bruising or any other problem at an injection site.